Connect with us

Hi, what are you looking for?

Wealthy Nation TodayWealthy Nation Today

Latest News

Fifteen killed in Israeli strikes on Damascus, Syrian state media say

Fifteen people were killed and 16 others injured in Israeli strikes on Damascus in Syria, state media SANA said, citing a military source and marking one of the deadliest strikes in months to hit the Syrian capital.

The strikes targeted several residential buildings in the upscale Mezzah neighborhood in the capital and the Qudsaya area in the Damascus countryside, Syrian state media reported. Among those killed were women and children, Syrian state media added.

The Israeli military said in a statement it was striking targets of the Islamic Jihad in Syria earlier Thursday and had “inflicted significant damage to the terrorist organization’s command center and to its operatives.”

Syrian state media said: “The Israeli enemy launched an aerial attack from the direction of the occupied Syrian Golan, targeting several residential buildings in the Mezzah neighborhood of Damascus and the Qudsaya area in the Damascus countryside.

“This resulted in the martyrdom of fifteen people and the injury of sixteen others, including women and children, as an initial toll, along with significant material damage to private property and the targeted and neighboring buildings,” Syrian state media said.

This is a developing story and will be updated.

This post appeared first on cnn.com

You May Also Like

Stock News

One of several effective StockCharts tools you can use to spot potential trading or investing opportunities is to check the New Highs panel in...

Latest News

Republican Congresswoman Claudia Tenney of New York is reacting to the House passage of the SAVE Act that she co-sponsored, which aims to prevent...

Latest News

More than half a million people have been evacuated from their homes as Super Typhoon Man-yi made landfall along the eastern coast of Catanduanes,...

Investing News

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...